ArticleFood science & nutrition2026
Inhibition of IL-6/STAT3 Signaling by N-Trans-Hibiscusamide and Its Derivative in a Mouse Model of Collagen-Induced Arthritis.
Article in Food science & nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rheumatoid arthritis is a chronic autoimmune disease characterized by persistent joint inflammation and progressive joint destruction, leading to pain, disability, and reduced quality of life. Interleukin-6 is a key pro-inflammatory cytokine that plays a central role in the pathogenesis of rheumatoid arthritis by activating downstream inflammatory signaling pathways. Dysregulation of the interleukin-6-mediated signaling cascade, particularly the signal transducer and activator of transcription 3 pathway, contributes to sustained inflammation and disease progression, highlighting this axis as an important therapeutic target. Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by joint inflammation and destruction, with interleukin-6 (IL-6) playing a central role in its pathogenesis by driving inflammatory responses. Targeting the IL-6/signal transducer and activator of transcription 3 (STAT3) pathway has emerged as a promising therapeutic approach for RA. This study investigates the inhibitory effects and underlying mechanisms of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.